1. a Istituto di Ricerche Farmacologiche “Mario Negri,” Department of Occupational Health, University of Milan, Milan, Italy;
2. b International Prevention Research Institute (i-PRI), Lyon, France;
3. c University of Texas MD Anderson Cancer Center, Houston, Texas, USA;
4. d Massachusetts General Hospital, Boston, Massachusetts, USA